NCT00072046
Clinical Trial Information
Trial Number: NCT00072046 (ClinicalTrials.gov)
Disease Type:
- Kidney Neoplasm - Renal Cell Carcinoma
Trial Title:
A Randomized Phase III Trial Of Interferon Alfa-2B Or Interferon Alfa-2B Plus Bevacizumab In Patients With Advanced Renal Carcinoma
Study ID:
CALGB-90206
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®